Clal Biotechnology | CBI - Pre Tax Profit


Clal Biotechnology reported ILS86.82M in Pre-Tax Profit for its fiscal quarter ending in December of 2022.





Pre Tax Profit Change Date
Arca Biopharma USD -21M 4.78M Mar/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Bio Path USD -2.85M 99K Mar/2025
Brainstorm Cell Therapeutics USD -2.86M 109K Mar/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -6.94M 421K Sep/2025
Immunic USD -21.38M 8.2M Jun/2024
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
RedHill Biopharma USD -1.54M 12M Jun/2024
TherapeuticsMD USD -1.05M 241K Jun/2024